Table 1.

Peritoneal Cell Surface Marker Distribution Within Forward/Side Scatter Regions

Surface Markers % Positive Cells
Region 1 Region 2
0 h 16 h 96 h 0 h 16 h 96 h
c-Fms  72 (2) 35 (3)  92 (1)  5 (1)  14 (1)  72 (5)  
F4/80 74 (5)  22 (8)  8 (3)  5 (1)  9 (3)  19 (5) 
MUM-4  37 (1)  ND  2 (1)  ND  0  
Class II  12 (1)  35 (4) 29 (1)  57 (14)  8 (2)  10 (2)  
T and B  3 (1) 6 (1)  1  76 (5)  26 (2)  44 (3)  
Mac-1 83 (6)  92 (1)  95 (1)  19 (8)  90 (1) 79 (5) 
Surface Markers % Positive Cells
Region 1 Region 2
0 h 16 h 96 h 0 h 16 h 96 h
c-Fms  72 (2) 35 (3)  92 (1)  5 (1)  14 (1)  72 (5)  
F4/80 74 (5)  22 (8)  8 (3)  5 (1)  9 (3)  19 (5) 
MUM-4  37 (1)  ND  2 (1)  ND  0  
Class II  12 (1)  35 (4) 29 (1)  57 (14)  8 (2)  10 (2)  
T and B  3 (1) 6 (1)  1  76 (5)  26 (2)  44 (3)  
Mac-1 83 (6)  92 (1)  95 (1)  19 (8)  90 (1) 79 (5) 

Six surface markers (see the Materials and Methods) were used to help define regions from the forward/side scatter profiles represented in Fig 3 (see text). Peritoneal cells were taken before (0 hours) and after (16 and 96 hours) TM injection. Region 1: “macrophage” region at t = 0; Region 2: “lymphocyte” region at t = 0, “lymphocyte/macrophage” region after 16 hours. Data are presented as a percentage of the cells within the region expressing the particular marker. Data are the mean (SEM) from 3 experiments (8 mice). A partial kinetic analysis was also performed another 8 times.

Abbreviation: ND, not done.

Close Modal

or Create an Account

Close Modal
Close Modal